Latest Engineering News

Arovella Therapeutics has secured TGA confirmation to advance its Phase 1 trial of ALA-101 in Australia via the efficient Clinical Trial Notification pathway, following FDA clearance in the US.

Verbrec Limited has promoted Mark Read from CEO to Managing Director, extending his notice period to ensure leadership continuity as the company builds on its recent turnaround.

ABx Group has announced a breakthrough with its second mixed rare earth carbonate sample from Tasmania’s Deep Leads deposit, boasting higher heavy rare earth content and fewer impurities. This advancement enhances project flexibility and strengthens ABx’s position in the competitive rare earths market.

NH3 Clean Energy has locked in a crucial 15-year water supply agreement with the Water Corporation of WA for its flagship WAH2 clean ammonia project, marking a key step towards its final investment decision.

MC Mining reports a modest improvement in half-year losses despite declining coal production and revenue, while advancing its Makhado Project and suspending Uitkomst operations to curb cash losses.

Locksley Resources has produced 99.5% pure antimony trioxide from its Desert Antimony Mine feedstock, marking a key step toward restoring a fully domestic U.S. supply chain for this critical mineral.

Frontier Energy has secured indicative senior debt terms worth around $220 million for its Waroona Renewable Energy Project, moving closer to finalising financing and supply contracts. The company is also considering mezzanine financing to optimise its funding structure.

ABx Group has secured partnerships in two major Australian Government R&D initiatives aimed at advancing rare earths refining and exploration technologies, accelerating development of its ionic clay rare earth project in Tasmania.

Condor Energy has updated its corporate presentation revealing significant progress in Peru’s Tumbes Basin, highlighting a 1 trillion cubic feet gas discovery and a multi-billion barrel oil exploration portfolio. The company is moving towards converting its evaluation agreement into a full exploration licence while advancing commercial discussions for gas offtake.

Patrys has initiated manufacturing and regulatory steps for RLS-2201, its injectable Quetiapine formulation targeting delirium, aiming for Phase 0 trials in the second half of 2026.

NuEnergy Gas Limited has completed four wells under its Tanjung Enim Early Gas Sales Initiative, secured a binding gas sales agreement, and raised $3.5 million to advance its Indonesian coal bed methane projects.

Briscoe Group Limited reported record full-year sales of NZD 798.8 million for FY2026, with net profit after tax dipping slightly to NZD 59.2 million. The company maintained dividends and invested heavily in supply chain upgrades despite a challenging retail environment.